Image Processing, Modeling and Simulation Software

The Food and Drug Administration (FDA) is seeking a cloud-based image analysis platform to assess the impact of process parameters and material attributes on product quality attributes. The platform should provide a comprehensive workflow, data management, storage management, and computing resource management capability. It should also demonstrate a proven track record in solving pharmaceutical and regulatory science challenges involving imaging data. The contract will be for a 12-month term, with an option for renewal. The FDA is looking for a firm fixed price purchase order, and the required delivery date for the items is on or before September 30, 2026. Some key features of the required platform include: • Providing a comprehensive workflow, data management, storage management, and computing resource management capability • Managing and sharing large volumes of image and quantitative data • Creating and managing complex image processing workflows • Segmenting complex imaging data from pharmaceutical samples using traditional, machine learning, and deep learning techniques • Extracting quantitative information from complex data to make real-world decisions • Predictively simulating critical quality attributes of various complex datasets • Having a browser-based user interface with multi-user support • Being deployed on FDA HCP clusters with a Linux-based system • Meeting the required system specifications, including Google Chrome browser, 8-core CPU, 128G memory, and instance storage of 2T or more.